
Cowin Venture
Description
Cowin Capital, often referred to as Cowin Venture, stands as a well-established venture capital firm in China, primarily headquartered in Shenzhen. Founded in 2000, the firm has built a significant presence in the Chinese investment landscape over two decades. It operates with a broad mandate, encompassing investments across various stages from early-stage and growth-stage companies to pre-IPO opportunities. This strategic flexibility allows Cowin Capital to support companies throughout their lifecycle, from initial development to market leadership.
The firm's investment strategy is primarily focused on high-growth sectors critical to China's economic transformation. Its core areas of interest include Technology, Media, and Telecommunications (TMT), Healthcare, New Energy, and Advanced Manufacturing. Within these sectors, Cowin Capital seeks companies demonstrating strong innovation, significant market potential, and robust management teams. Their diversified sector focus enables them to capitalize on emerging trends and contribute to the development of key industries.
Cowin Capital manages substantial assets, with over $1.4 billion in assets under management across multiple funds. This considerable capital base underpins its ability to make significant investments. The firm boasts an active portfolio, having completed over 120 investments and achieved more than 40 successful exits, underscoring its track record of identifying and nurturing successful ventures. For instance, its Cowin Capital Fund V, launched in 2020, successfully raised approximately 2.5 billion RMB, further solidifying its capacity for new investments.
Given its extensive fund sizes and multi-stage investment approach, Cowin Capital's typical first cheque sizes vary considerably. For early-stage opportunities, initial investments generally range from $1 million to $5 million, providing crucial seed or Series A capital. However, for more mature growth-stage or pre-IPO companies, the firm is capable of deploying significantly larger amounts, with first cheques potentially reaching up to $50 million or more, reflecting its capacity to lead substantial funding rounds.
Investor Profile
Cowin Venture has backed more than 24 startups, with 8 new investments in the last 12 months alone. The firm has led 7 rounds, about 29% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series E rounds (top funding stages).
- Majority of deals are located in United States, China, Hong Kong.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Led 1 rounds in the past year.
- Typical check size: $1M – $50M.
Stage Focus
- Series A (46%)
- Series B (25%)
- Series E (8%)
- Seed (8%)
- Series Unknown (4%)
- Angel (4%)
- Series C (4%)
Country Focus
- United States (54%)
- China (42%)
- Hong Kong (4%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Life Science
- Health Diagnostics
- Clinical Trials
- Biopharma
- Cloud Computing
- Pharmaceutical
- Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.